New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

35

Newly Discovered Gene Doubles Severe COVID-19 Risk and WHO Updates Guidelines

The World Health Organization updated WHO’s treatment guidelines for COVID-19 for the eighth time, recommending baricitinib for individuals with severe COVID-19 when used with corticosteroids. In other news, researchers from the Medical University of Bialystok in Poland identified a gene that appears to double the risk of severe COVID-19.

37

J&J booster 85% effective against Omicron hospitalization, South Africa says

A Johnson and Johnson COVID-19 vaccine booster shot is 85 percent effective in protecting against being hospitalized by the Omicron variant for 1-2 months after the shot is received, the head of South Africa’s Medical Research Council (SAMRC) said on January 14.

40

JPM Day 3: AbbVie Sees Bright Future Ahead, vTv, Gritstone and Achilles

Since acquiring Allergan for $63 billion in 2019, AbbVie said it’s “tracking well” against the financial commitment the company made when striking the deal. Chief Financial Officer Rob Michael said at the 2022 J.P. Morgan Healthcare Conference the company is exceeding AbbVie’s revenue expectations in the aesthetics market, led by Botox.